Six drug companies are actively developing RSV vaccines or antibodies, which suggests this year could be the last one without adequate tools to fight the virus.
As winter approaches, hospitals across the country are filling up with sick children. Here's what we know about RSV and other respiratory viruses. with young children fighting a virus few adults know much about.
Through the first 90 days of a baby's life, the vaccine was more than 80% effective at preventing severe illness. At six months, it remained nearly 70% effective, the study showed. The trial did not raise any major safety concerns for either parent or child. "The majority of hospitalization and severe disease caused by RSV happen in that first year of life," he said."It's critical to protect these infants."
Ever since, companies have been working on RSV prevention tools, many of which are coming to fruition at the same time. Moderna is six months behind other companies, CEO Stéphane Bancel said in a September interview, but expects this month to have safety data for the first 6,000 trial participants six months after their shot. Depending on infection rates, the company will have an interim analysis some time in the winter or spring, he said.
That's why she was thrilled when pregnant with her second daughter last year to be able to sign up for a clinical trial of Pfizer's RSV vaccine at Cincinnati Children's where she works.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Read more »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Read more »
Pfizer announces promising developments for 1st maternal RSV vaccineAfter decades of researching respiratory syncytial virus, an illness especially dangerous for newborns and the elderly, scientists this week announced a major development in plans for a possible vaccine that could be available as soon as next year.
Read more »
RSV Vaccine Given During Pregnancy Protects Newborns: PfizerNew trial data from drugmaker Pfizer shows promising effectiveness of a vaccine given to mothers during pregnancy that later protects infants in their first months from the most devastating effects of respiratory syncytial virus, or RSV.
Read more »
Pfizer Says It Will Seek FDA Approval For A Maternal RSV Vaccine This YearInitial trail results of the maternal vaccine showed promising results for Pfizer. The pharmaceutical company will seek FDA approval this week.
Read more »
RSV vaccine under development as pediatric cases surge at SoCal hospitalsPfizer's vaccine for RSV might be only a year away, providing some hope as cases surge at SoCal hospitals this year.
Read more »